Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026)
Emergent BioSolutions (EBS) posted Other Non-Current Liabilities of $35.4 million for Q2 2026, down 15.11% on a QoQ basis from $41.7 million in Q1 2026, and down 10.38% year-over-year from $39.5 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Other Non-Current Liabilities for 17 years, with the latest figure at $35.4 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 10.38% year-over-year to $35.4 million in Q2 2026; TTM through Jun 2026 was $35.4 million, a 10.38% decrease from a year earlier, with the FY2025 full-year figure at $53.9 million, up 37.85% from the prior year.
- Other Non-Current Liabilities was $35.4 million for Q2 2026 at Emergent BioSolutions, down from $41.7 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $58.5 million in Q2 2022, with the low at $23.4 million in Q2 2023.
- Average Other Non-Current Liabilities over 5 years is $38.1 million, with a median of $37.4 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities plunged 60.0% in 2023, then surged 53.7% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $41.5 million in 2022, then tumbled by 30.36% to $28.9 million in 2023, then surged by 35.29% to $39.1 million in 2024, then soared by 37.85% to $53.9 million in 2025, then sank by 34.32% to $35.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $35.4 million (Q2 2026), $41.7 million (Q1 2026), and $53.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.40 Mn |
| Mar 31, 2026 | 41.70 Mn |
| Dec 31, 2025 | 53.90 Mn |
| Sep 30, 2025 | 42.60 Mn |
| Jun 30, 2025 | 39.50 Mn |
| Mar 31, 2025 | 35.40 Mn |
| Dec 31, 2024 | 39.10 Mn |
| Sep 30, 2024 | 35.80 Mn |
| Jun 30, 2024 | 25.70 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 28.90 Mn |
| Sep 30, 2023 | 31.30 Mn |
| Jun 30, 2023 | 23.40 Mn |
| Mar 31, 2023 | 24.10 Mn |
| Dec 31, 2022 | 41.50 Mn |
| Sep 30, 2022 | 52.30 Mn |
| Jun 30, 2022 | 58.50 Mn |
| Mar 31, 2022 | 49.30 Mn |
| Dec 31, 2021 | 69.50 Mn |
| Sep 30, 2021 | 58.70 Mn |
API Access
Emergent BioSolutions Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();